Antibody Titers Against Oxidized LDL Are Not Elevated in Patients With Familial Hypercholesterolemia
- 1 August 1998
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 18 (8), 1203-1211
- https://doi.org/10.1161/01.atv.18.8.1203
Abstract
Abstract —Antibodies against oxidized low density lipoproteins (Ox-LDLs) have been proposed to be independent predictors of atherosclerosis development. The main aims of the current study were to (1) compare antibody titers to Ox-LDL in patients with heterozygous familial hypercholesterolemia (n=51) with those in matched controls (n=45) and (2) analyze whether the antibody titers were related to the extent of atherosclerosis, as assessed cross-sectionally and prospectively by ultrasonography in the 2 study groups. Antibody titers were determined with a solid-phase ELISA, and plates were coated with the antigens Ox-LDL or malondialdehyde-treated LDL (MDA-LDL) as well as with the postcoat only (5% dry milk powder). Antibody titers were expressed as absorbance [(value in patient serum minus that in postcoat) divided by (Internal Standard Serum minus postcoat)]. There were no significant differences in antibody titers against Ox-LDL or MDA-LDL between the group of patients with familial hypercholesterolemia and the controls. In cross-sectional comparisons, no significant associations were observed between the intima-media thickness of the carotid or femoral arteries and antibody titers against Ox-LDL or between plaque occurrence and these titers. Patients with a history of myocardial infarction had significantly lower IgM titers against Ox-LDL compared with patients without a history of myocardial infarction and with controls. In conclusion, mean values for antibody titers against Ox-LDL were not increased in the patient group compared with a healthy control group, and no positive, significant relationship was observed between antibody titers and the extent of atherosclerosis, as measured by ultrasound, in the carotid or femoral arteries. Taken together, these findings indicate that the relationship between the autoimmune response to Ox-LDL and the extent of atherosclerosis is more complex than previously anticipated.Keywords
This publication has 17 references indexed in Scilit:
- IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.JCI Insight, 1997
- Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controlsAtherosclerosis, 1996
- Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosisAmerican Heart Journal, 1996
- Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three-year ultrasound study of common carotid and femoral arteriesAtherosclerosis, 1995
- Carotid artery intima‐media thickness as an indicator of generalized atherosclerosisJournal of Internal Medicine, 1994
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992
- Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing systemClinical Physiology and Functional Imaging, 1991
- Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitroAtherosclerosis, 1990
- Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990